MintNeuro secures £17M in non-dilutive ARIA funding for neural implant semiconductor technology
Summary
MintNeuro has been awarded three major funding contracts totaling £17 million from the UK government's Advanced Research and Invention Agency (ARIA) as part of its £69 million Precision Neurotechnologies programme. The Imperial College London spinout develops scalable, low-power semiconductor technology for minimally-invasive neural implants, and will lead chip development across three projects targeting epilepsy, depression, and stroke.
Why it matters
Traditional neural implant technologies are bulky and power-intensive, relying on invasive surgery that increases patient risk. MintNeuro's semiconductor-based approach enables smaller, more efficient, and scalable neural implants that could transform treatment for neurological conditions including epilepsy, Parkinson's, and neuropsychiatric disorders. The ARIA funding underscores the UK's commitment to becoming a leader in neurotechnology.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial